These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
475 related items for PubMed ID: 18342588
1. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588 [Abstract] [Full Text] [Related]
2. Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study. Moghimi-Dehkordi B, Vahedi M, Khoshkrood Mansoori B, Kasaeian A, Safaee A, Habibi M, Pourhoseingholi A, Pourhoseingholi MA, Zali MR. Arab J Gastroenterol; 2011 Jun; 12(2):86-9. PubMed ID: 21684479 [Abstract] [Full Text] [Related]
3. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Willich SN, Nocon M, Kulig M, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P. Aliment Pharmacol Ther; 2006 Feb 01; 23(3):371-6. PubMed ID: 16422996 [Abstract] [Full Text] [Related]
4. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. Eur J Gastroenterol Hepatol; 2007 Jun 01; 19(6):499-506. PubMed ID: 17489061 [Abstract] [Full Text] [Related]
5. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on. Pace F, Bollani S, Molteni P, Bianchi Porro G. Dig Liver Dis; 2004 Feb 01; 36(2):111-5. PubMed ID: 15002817 [Abstract] [Full Text] [Related]
6. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population. Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Solhpour A, Habibi M, Zali MR. Eur J Gastroenterol Hepatol; 2008 Aug 01; 20(8):719-25. PubMed ID: 18617775 [Abstract] [Full Text] [Related]
7. Burden of illness in Italian patients with gastro-oesophageal reflux disease. Pacini F, Calabrese C, Cipolletta L, Valva MD, Russo A, Savarino V, Vigneri S. Curr Med Res Opin; 2005 Apr 01; 21(4):495-502. PubMed ID: 15899097 [Abstract] [Full Text] [Related]
8. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study. Wong WM, Lai KC, Lam KF, Hui WM, Huang JQ, Xia HH, Hu WH, Lam CL, Chan CK, Lam SK, Wong BC. Aliment Pharmacol Ther; 2004 Oct 01; 20(7):803-12. PubMed ID: 15379841 [Abstract] [Full Text] [Related]
9. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Jones R, Coyne K, Wiklund I. Aliment Pharmacol Ther; 2007 Jun 15; 25(12):1451-9. PubMed ID: 17539985 [Abstract] [Full Text] [Related]
10. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Pace F, Negrini C, Wiklund I, Rossi C, Savarino V, ITALIAN ONE INVESTIGATORS STUDY GROUP. Aliment Pharmacol Ther; 2005 Aug 15; 22(4):349-56. PubMed ID: 16098002 [Abstract] [Full Text] [Related]
11. [Prevalence of gastro-oesophageal reflux disease in general practice]. Hollenz M, Stolte M, Labenz J. Dtsch Med Wochenschr; 2002 May 10; 127(19):1007-12. PubMed ID: 11997867 [Abstract] [Full Text] [Related]
12. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study. Bretagne JF, Rey JF, Caekaert A, Barthélemy P. Dig Liver Dis; 2005 Aug 10; 37(8):566-70. PubMed ID: 15886080 [Abstract] [Full Text] [Related]
13. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population. Cheung TK, Lam KF, Hu WH, Lam CL, Wong WM, Hui WM, Lai KC, Lam SK, Wong BC. Aliment Pharmacol Ther; 2007 May 01; 25(9):1099-104. PubMed ID: 17439511 [Abstract] [Full Text] [Related]
14. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA. Aliment Pharmacol Ther; 2008 May 01; 27(10):960-70. PubMed ID: 18315585 [Abstract] [Full Text] [Related]
15. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Talley NJ. Aliment Pharmacol Ther; 2004 Jul 01; 20 Suppl 2():23-30. PubMed ID: 15335410 [Abstract] [Full Text] [Related]
16. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission. Oudkerk Pool M. Aliment Pharmacol Ther; 2007 Dec 01; 26 Suppl 2():13-6. PubMed ID: 18081644 [Abstract] [Full Text] [Related]
17. Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. Nordic GORD Study Group. Gastro-oesophageal reflux disease. Lundell L, Dalenbäck J, Janatuinen E, Hattlebakk J, Levander K, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Andersson A, Stålhammar NO. Br J Surg; 1998 Jul 01; 85(7):1002-5. PubMed ID: 9692584 [Abstract] [Full Text] [Related]
18. Irritable bowel syndrome, gastro-oesophageal reflux disease and dyspepsia: overlap analysis using loglinear models. Pourhoseingholi A, Vahedi M, Pourhoseingholi MA, Ashtari S, Moghimi-Dehkordi B, Safaee A, Zali MR. Arab J Gastroenterol; 2012 Mar 01; 13(1):20-3. PubMed ID: 22560820 [Abstract] [Full Text] [Related]
19. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Jaspersen D, Labenz J, Willich SN, Kulig M, Nocon M, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Stolte M, Malfertheiner P. Dig Liver Dis; 2006 Apr 01; 38(4):233-8. PubMed ID: 16413233 [Abstract] [Full Text] [Related]
20. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Brook RA, Wahlqvist P, Kleinman NL, Wallander MA, Campbell SM, Smeeding JE. Aliment Pharmacol Ther; 2007 Sep 15; 26(6):889-98. PubMed ID: 17767473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]